BRCA2 and ductal breast carcinoma in situ: They observed frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6, and WT1 genes in both DCIS and adjacent invasive ductal adenocarcinoma lesions.